press and news

• Helén Tuvesson

  President & CEO

  

  +46 46 19 21 56helen.tuvesson@activebiotech.com

• Hans Kolam

  Chief Financial Officer

  

  +46 46 19 20 44hans.kolam@activebiotech.com

Press Releases

• Press Release

  Active Biotech Strengthens Global Patent Protection for Laquinimod with Patent Grant in Japan

  2026-09-30

• Press Release

  Active Biotech Interim Report Q2 2026

  2026-08-20

  Regulatory

• Press Release

  Active Biotech expands US collaboration to advance tasquinimod clinical development in myelofibrosis

  2026-08-18

• Press Release

  First patient dosed in the amended HO172 clinical study of tasquinimod in myelofibrosis

  2026-07-24

• Press Release

  Number of shares and votes in Active Biotech

  2026-06-30

  Regulatory

• Press Release

  Active Biotech announces timetable for reverse share split

  2026-05-28

  Regulatory